Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$22.97 - $30.58 $505 - $672
-22 Reduced 0.22%
10,116 $276,000
Q3 2023

Nov 14, 2023

SELL
$22.72 - $31.49 $2.06 Million - $2.85 Million
-90,499 Reduced 89.93%
10,138 $246,000
Q2 2023

Aug 14, 2023

SELL
$25.3 - $39.67 $11.8 Million - $18.6 Million
-468,100 Reduced 82.31%
100,637 $2.79 Million
Q1 2023

May 15, 2023

SELL
$30.21 - $48.1 $1.28 Million - $2.04 Million
-42,466 Reduced 6.95%
568,737 $18.9 Million
Q4 2022

Feb 14, 2023

SELL
$22.28 - $38.71 $146,424 - $254,402
-6,572 Reduced 1.06%
611,203 $18.8 Million
Q3 2022

Nov 14, 2022

SELL
$34.2 - $51.69 $1.47 Million - $2.22 Million
-42,852 Reduced 6.49%
617,775 $21.1 Million
Q2 2022

Aug 15, 2022

SELL
$23.14 - $49.68 $9.12 Million - $19.6 Million
-394,274 Reduced 37.38%
660,627 $22.9 Million
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $905,746 - $2.1 Million
-32,616 Reduced 3.0%
1,054,901 $46.4 Million
Q4 2021

Feb 14, 2022

SELL
$54.9 - $105.21 $1.08 Million - $2.07 Million
-19,696 Reduced 1.78%
1,087,517 $68.4 Million
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $5.11 Million - $8.67 Million
48,624 Added 4.59%
1,107,213 $117 Million
Q2 2021

Aug 16, 2021

SELL
$125.11 - $180.0 $11.4 Million - $16.4 Million
-91,022 Reduced 7.92%
1,058,589 $187 Million
Q1 2021

May 17, 2021

BUY
$126.27 - $191.71 $2.98 Million - $4.52 Million
23,587 Added 2.09%
1,149,611 $153 Million
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $1.23 Million - $2.04 Million
15,040 Added 1.35%
1,126,024 $152 Million
Q3 2020

Nov 16, 2020

SELL
$73.3 - $89.48 $1.67 Million - $2.04 Million
-22,748 Reduced 2.01%
1,110,984 $92.4 Million
Q2 2020

Aug 14, 2020

SELL
$48.82 - $82.53 $1.19 Million - $2.01 Million
-24,334 Reduced 2.1%
1,133,732 $93.1 Million
Q1 2020

May 15, 2020

SELL
$39.1 - $62.9 $903,992 - $1.45 Million
-23,120 Reduced 1.96%
1,158,066 $59.6 Million
Q4 2019

Feb 14, 2020

SELL
$29.79 - $43.06 $644,655 - $931,818
-21,640 Reduced 1.8%
1,181,186 $49.1 Million
Q3 2019

Nov 14, 2019

BUY
$30.47 - $37.65 $1.19 Million - $1.47 Million
38,940 Added 3.35%
1,202,826 $38.9 Million
Q2 2019

Aug 13, 2019

BUY
$25.73 - $35.79 $6.71 Million - $9.33 Million
260,727 Added 28.87%
1,163,886 $40.6 Million
Q1 2019

May 17, 2019

BUY
$21.71 - $31.54 $510,597 - $741,789
23,519 Added 2.67%
903,159 $26.7 Million
Q4 2018

Feb 14, 2019

BUY
$14.95 - $24.72 $628,468 - $1.04 Million
42,038 Added 5.02%
879,640 $20.4 Million
Q3 2018

Oct 30, 2018

SELL
$17.8 - $25.35 $431,988 - $615,219
-24,269 Reduced 2.82%
837,602 $16.3 Million
Q2 2018

Jul 31, 2018

SELL
$18.0 - $25.01 $755,712 - $1.05 Million
-41,984 Reduced 4.64%
861,871 $20 Million
Q1 2018

Apr 30, 2018

SELL
$20.05 - $26.96 $266,023 - $357,705
-13,268 Reduced 1.45%
903,855 $19.3 Million
Q4 2017

Jan 31, 2018

BUY
$21.23 - $34.09 $7.66 Million - $12.3 Million
360,801 Added 64.85%
917,123 $19.5 Million
Q3 2017

Nov 06, 2017

BUY
$27.0 - $31.11 $15 Million - $17.3 Million
556,322
556,322 $15 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.59B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.